Overview
About Allele Capital
Allele Capital is a premier advisory and merchant banking firm specializing in venture capital and private equity financing for private and micro/small-cap public life science companies.
We partner with our clients to provide a full suite of value-added services, including strategic advisory, proprietary capital deployment, and access to non-proprietary capital through Wilmington Capital Securities, LLC—a Registered Broker-Dealer, Member FINRA, MSRB, and SIPC. All securities transactions are conducted in compliance with FINRA and SEC regulations.
Through both advisory and capital-raising initiatives, Allele leverages a deep, proprietary network of industry advisers, C-suite executives, and key opinion leaders (KOLs) to drive growth and unlock value for corporate and investment partners.
Our Principals bring decades of experience in the private-to-public and public venture process, having facilitated the growth of small and micro-cap life sciences companies to valuations exceeding $2 billion—delivering substantial shareholder value in the process.
We partner with our clients to provide a full suite of value-added services, including strategic advisory, proprietary capital deployment, and access to non-proprietary capital through Wilmington Capital Securities, LLC—a Registered Broker-Dealer, Member FINRA, MSRB, and SIPC. All securities transactions are conducted in compliance with FINRA and SEC regulations.
Through both advisory and capital-raising initiatives, Allele leverages a deep, proprietary network of industry advisers, C-suite executives, and key opinion leaders (KOLs) to drive growth and unlock value for corporate and investment partners.
Our Principals bring decades of experience in the private-to-public and public venture process, having facilitated the growth of small and micro-cap life sciences companies to valuations exceeding $2 billion—delivering substantial shareholder value in the process.